Applications of Radiomics in Genitourinary Tumors

Overview

Journal Am J Cancer Res

Specialty Oncology

Date 2020 Sep 9

PMID 32905456

Citations 11

Authors

Longfei Liu

Xiaoping Yi

Can Lu

Lin Qi

Youming Zhang

Minghao Li

Qiao Xiao

Cikui Wang

Liang Zhang

Yingxian Pang

Yong Wang

Xiao Guan

Affiliations

Soon will be listed here.

Abstract

Genitourinary tumors are heterogeneous groups of tumors with high morbidity and mortality rates. Confronted with existing problems in the management of genitourinary tumors, a personalized imaging method called radiomics shows great potential in areas including detection, grading, and treatment response assessment. Radiomics is characterized by extraction of quantitative imaging features which are not visible to the naked eye from conventional imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography-computed tomography (PET-CT), followed by data analysis and model building. It outperforms other invasive methods in terms of non-invasiveness, low cost and high efficiency. Recently, a number of studies have evaluated the application of radiomics in patients with genitourinary tumors with promising data. The combination of radiomics and clinical/laboratory factors provides added value in many studies. Despite this, there are limitations and challenges to be overcome before a more extensive clinical application in the future. In this article, we will introduce the concept, significance and workflow of radiomics, review their current applications in patients with genitourinary tumors and discuss limitations and future directions of radiomics. It would help multidisciplinary team involved in the treatment of patients with genitourinary tumors to achieve a better understanding of the results of radiomics study toward a personalized medicine.

Citing Articles

MRI-derived radiomics models for diagnosis, aggressiveness, and prognosis evaluation in prostate cancer.

Zhu X, Shao L, Liu Z, Liu Z, He J, Liu J J Zhejiang Univ Sci B. 2023; 24(8):663-681.

PMID: 37551554 PMC: 10423970. DOI: 10.1631/jzus.B2200619.

Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions.

OSullivan N, Kelly M Curr Oncol. 2023; 30(5):4936-4945.

PMID: 37232830 PMC: 10217419. DOI: 10.3390/curroncol30050372.

A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072).

Liu W, Zeng C, Wang S, Zhan Y, Huang R, Luo T Front Oncol. 2023; 12:1026305.

PMID: 37078004 PMC: 10107369. DOI: 10.3389/fonc.2022.1026305.

Radiomics vs radiologist in bladder and renal cancer. Results from a systematic review.

Tramanzoli P, Castellani D, De Stefano V, Brocca C, Nedbal C, Chiacchio G Cent European J Urol. 2023; 76(1):12-19.

PMID: 37064257 PMC: 10091893. DOI: 10.5173/ceju.2023.252.

A machine learning approach to distinguishing between non-functioning and autonomous cortisol secreting adrenal incidentaloma on magnetic resonance imaging using texture analysis.

Piskin F, Akkus G, Yucel S, Unal I, Balli H, Olgun M Ir J Med Sci. 2022; 192(3):1155-1161.

PMID: 35877014 DOI: 10.1007/s11845-022-03105-8.

References

Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H . Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol. 2011; 21(10):2178-86. DOI: 10.1007/s00330-011-2174-7. View

Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, Morganti A . Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp. 2018; 2(1):36. PMC: 6234198. DOI: 10.1186/s41747-018-0068-z. View

Ma S, Xie H, Wang H, Han C, Yang J, Lin Z . MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer. J Magn Reson Imaging. 2019; 50(6):1914-1925. DOI: 10.1002/jmri.26777. View

Shu J, Wen D, Xi Y, Xia Y, Cai Z, Xu W . Clear cell renal cell carcinoma: Machine learning-based computed tomography radiomics analysis for the prediction of WHO/ISUP grade. Eur J Radiol. 2019; 121:108738. DOI: 10.1016/j.ejrad.2019.108738. View

Fan T, Malhi H, Varghese B, Cen S, Hwang D, Aron M . Computed tomography-based texture analysis of bladder cancer: differentiating urothelial carcinoma from micropapillary carcinoma. Abdom Radiol (NY). 2018; 44(1):201-208. DOI: 10.1007/s00261-018-1694-x. View

Parmar C, Grossmann P, Bussink J, Lambin P, Aerts H . Machine Learning methods for Quantitative Radiomic Biomarkers. Sci Rep. 2015; 5:13087. PMC: 4538374. DOI: 10.1038/srep13087. View

Zhao X, Nie F, Wang S, Guo J, Xu P, Chen X . Unsupervised 2D Dimensionality Reduction with Adaptive Structure Learning. Neural Comput. 2017; 29(5):1352-1374. DOI: 10.1162/NECO_a_00950. View

Schick U, Lucia F, Dissaux G, Visvikis D, Badic B, Masson I . MRI-derived radiomics: methodology and clinical applications in the field of pelvic oncology. Br J Radiol. 2019; 92(1104):20190105. PMC: 6913356. DOI: 10.1259/bjr.20190105. View

Zhang G, Han Y, Wei J, Qi Y, Gu D, Lei J . Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy. J Magn Reson Imaging. 2020; 52(4):1239-1248. DOI: 10.1002/jmri.27138. View

10.

Xu X, Liu Y, Zhang X, Tian Q, Wu Y, Zhang G . Preoperative prediction of muscular invasiveness of bladder cancer with radiomic features on conventional MRI and its high-order derivative maps. Abdom Radiol (NY). 2017; 42(7):1896-1905. DOI: 10.1007/s00261-017-1079-6. View

11.

Baessler B, Nestler T, Pinto Dos Santos D, Paffenholz P, Zeuch V, Pfister D . Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection. Eur Radiol. 2019; 30(4):2334-2345. DOI: 10.1007/s00330-019-06495-z. View

12.

Wu S, Zheng J, Li Y, Yu H, Shi S, Xie W . A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer. Clin Cancer Res. 2017; 23(22):6904-6911. DOI: 10.1158/1078-0432.CCR-17-1510. View

13.

Yi X, Pei Q, Zhang Y, Zhu H, Wang Z, Chen C . MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Front Oncol. 2019; 9:552. PMC: 6606732. DOI: 10.3389/fonc.2019.00552. View

14.

McCann S, Jiang Y, Fan X, Wang J, Antic T, Prior F . Quantitative Multiparametric MRI Features and PTEN Expression of Peripheral Zone Prostate Cancer: A Pilot Study. AJR Am J Roentgenol. 2016; 206(3):559-65. DOI: 10.2214/AJR.15.14967. View

15.

Bourbonne V, Vallieres M, Lucia F, Doucet L, Visvikis D, Tissot V . MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate Cancer. Front Oncol. 2019; 9:807. PMC: 6719613. DOI: 10.3389/fonc.2019.00807. View

16.

Smith C, Czarniecki M, Mehralivand S, Stoyanova R, Choyke P, Harmon S . Radiomics and radiogenomics of prostate cancer. Abdom Radiol (NY). 2018; 44(6):2021-2029. DOI: 10.1007/s00261-018-1660-7. View

17.

Nie P, Yang G, Wang Z, Yan L, Miao W, Hao D . A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma. Eur Radiol. 2019; 30(2):1274-1284. DOI: 10.1007/s00330-019-06427-x. View

18.

Rajesh A, Sokhi H, Fung R, Mulcahy K, Bankart M . Bladder cancer: evaluation of staging accuracy using dynamic MRI. Clin Radiol. 2011; 66(12):1140-5. DOI: 10.1016/j.crad.2011.05.019. View

19.

Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat E . EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2016; 71(3):447-461. DOI: 10.1016/j.eururo.2016.05.041. View

20.

Suzuki K . Overview of deep learning in medical imaging. Radiol Phys Technol. 2017; 10(3):257-273. DOI: 10.1007/s12194-017-0406-5. View